Literature DB >> 26706044

Procalcitonin-guidance reduces antibiotic exposure in children with nosocomial infection (PRORANI).

Cristian Launes1, Elisabeth Esteban2, Mònica Balaguer2, Miquel Alsina2, Francisco-José Cambra2, Iolanda Jordan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26706044     DOI： 10.1016/j.jinf.2015.12.001

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  5 in total

1.  Procalcitonin Is a Better Biomarker than C-Reactive Protein in Newborns Undergoing Cardiac Surgery: The PROKINECA Study.

Authors:  Sara Bobillo Pérez; Javier Rodríguez-Fanjul; Iolanda Jordan García; Julio Moreno Hernando; Martín Iriondo Sanz
Journal:  Biomark Insights       Date:  2016-11-03

Review 2.  Is Procalcitonin Useful in Pediatric Critical Care Patients?

Authors:  Sara Bobillo-Perez; Javier Rodríguez-Fanjul; Iolanda Jordan Garcia
Journal:  Biomark Insights       Date:  2018-08-07

3.  Procalcitonin to stop antibiotics after cardiovascular surgery in a pediatric intensive care unit-The PROSACAB study.

Authors:  Sara Bobillo-Perez; Anna Sole-Ribalta; Monica Balaguer; Elisabeth Esteban; Monica Girona-Alarcon; Lluisa Hernandez-Platero; Susana Segura; Aida Felipe; Francisco Jose Cambra; Cristian Launes; Iolanda Jordan
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

4.  Procalcitonin and lung ultrasound algorithm to diagnose severe pneumonia in critical paediatric patients (PROLUSP study). A randomised clinical trial.

Authors:  Javier Rodríguez-Fanjul; Carmina Guitart; Sara Bobillo-Perez; Mònica Balaguer; Iolanda Jordan
Journal:  Respir Res       Date:  2020-10-08

Review 5.  Kinetics of Procalcitonin in Pediatric Patients on Extracorporeal Membrane Oxygenation.

Authors:  Sara Bobillo; Javier Rodríguez-Fanjul; Anna Solé; Julio Moreno; Mònica Balaguer; Elisabeth Esteban; Francisco José Cambra; Iolanda Jordan
Journal:  Biomark Insights       Date:  2018-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.